Is There a Relationship Between Limited English Proficiency (LEP), Medication Adherence Behaviors, and Adverse Asthma Outcomes in Hispanic Adults with Moderate to Severe Persistent Asthma? by Chandra, Archana Kartik
San Jose State University
SJSU ScholarWorks
Doctoral Projects Master's Theses and Graduate Research
4-2019
Is There a Relationship Between Limited English
Proficiency (LEP), Medication Adherence
Behaviors, and Adverse Asthma Outcomes in
Hispanic Adults with Moderate to Severe Persistent
Asthma?
Archana Kartik Chandra
Follow this and additional works at: https://scholarworks.sjsu.edu/etd_doctoral
Part of the Other Nursing Commons, and the Public Health and Community Nursing Commons
CALIFORNIA STATE UNIVERSITY, FRESNO 
THE DIVISION OF GRADUATE STUDIES 
DISSERTATION/THESIS OFFICE 
ABSTRACT 
IS THERE A RELATIONSHIP BETWEEN LIMITED ENGLISH 
PROFICIENCY (LEP), MEDICATION ADHERENCE BEHAVIORS, AND 
ADVERSE ASTHMA OUTCOMES IN HISPANIC ADULTS WITH 
MODERATE TO SEVERE PERSISTENT ASTHMA? 
 The effects of LEP are well documented in the literature. LEP decreases 
medication adherence, causes ineffective communication between patients and providers, and 
reduces health outcomes. Asthma is known to be misdiagnosed and under-treated in Hispanic 
adults.There are discrepancies in the literature about the effects of LEP in Hispanic adults with 
persistent asthma.  
The purpose of this study was to determine if the presence of LEP is associated with 
medication adherence behaviors and adverse asthma outcomes in Hispanic adults with moderate 
to severe persistent asthma. Hispanic adults with LEP were assessed for asthma outcomes and 
medication adherence behaviors.  
The results of this study revealed that there is no correlation between the level of English 
proficiency, asthma outcomes, and medication adherence behaviors in Hispanic adults with LEP. 
These findings are a fundamental step towards mitigating the current gaps in the literature. With 
the Hispanic population on the rise, further research is needed to develop effective interventions 
that will advance the delivery of asthma care and relieve the burdens of asthma management in 
Hispanic adults struggling with LEP. 
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CHAPTER 1: INTRODUCTION 
Introduction
 The considerable adverse effects of language barriers such as limited English proficiency 
(LEP), on the quality of health outcomes, have been well documented in the literature (Schwei et 
al., 2016). Previous research studies have confirmed that the presence of LEP hinders patients’ 
access to healthcare services, leads to misconceptions regarding health and self-management 
information, affects medication adherence, causes a reduction in the overall quality of care 
provided by clinicians, and subsequently, affects patient-provider relationship satisfaction 
(Schwei et al., 2016). The Hispanic population, especially, is widely affected by the presence of 
LEP. Presently, the Hispanics are believed to be the largest and most rapidly growing minority 
group in the United States (US), accounting for 54 million individuals and comprising 17% of 
the country’s population (Schembri & Ghaddar, 2017; Sarkar, Asti, Nacion, & Chisolm, 2016). 
According to the US Census Bureau, in 2010, approximately 37.5% of the population reported 
Spanish as their primary language; 44% of whom were believed to have some level of LEP 
(Riera et al., 2015). Spanish-speakers with LEP are more likely to receive suboptimal health 
care, experience miscommunication, and be subjected to shorter and less patient-centered office 
visits (White, 2015).  
 Asthma remains one of the most prevalent chronic diseases in the US. It has been well 
documented in the literature that the effects of asthma disproportionately influence individuals 
belonging to ethnic and racial minority groups (McQuaid, 2018). According to Sofianou et al. 
(2012), asthma symptoms are generally misdiagnosed or under-treated in older adult patients. 
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Furthermore, the majority of the research and therapy guidelines on asthma thus far have been 
essentially directed towards the pediatric population, although earlier studies have confirmed that  
morbidity and mortality levels are significantly higher among older adults with asthma (Sofianou 
et al., 2012). This has resulted in a conspicuous discrepancy in the data available in the literature 
regarding the management of asthma within the adult population. Medication non-adherence, a 
prevalent health issue affecting Hispanics with LEP, has been observed across the life-span of 
these individuals, and contributes to adverse health outcomes, mainly pertaining to the 
management of chronic diseases such as asthma (White, 2015; McQuaid & Landier, 2017). The 
current treatment guidelines on asthma have highlighted the regular use of controller medications 
as one of the fundamental components associated with improved outcomes in long-term 
management of persistent asthma (McQuaid, 2018). Studies performed by the National 
Assessment of Adult Literacy (NAAL) and the Pew Research Center have substantiated that 
Hispanics have the lowest levels of health literacy when compared to other minority groups in 
the US. The decreased level of health literacy in this population is associated with erroneous use 
of medications and decreased medication adherence (Sarkar et al., 2016). Research findings have 
corroborated that culture may play a crucial role in influencing individual beliefs about 
medication usage and adherence. Due to cultural differences, Hispanic patients are more likely to 
have opposing beliefs regarding the regular use of controller medications necessary for the 
management of persistent asthma (Ahmed & Bates, 2017; McQuaid, 2018).  
 As the Hispanic population in the US continues to grow, further research is required to 
mitigate the gaps that currently exist in the literature regarding the management of chronic 
asthma in Hispanic adults with LEP. The findings from these studies will assist healthcare 
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providers to understand the dynamic needs of this population and lead the way to providing the 
high quality and culturally competent care necessary to improve long-term asthma outcomes  
within the adult Hispanic population. The intent of this study is to determine if there is a 
relationship between LEP, medication adherence behaviors, and asthma outcomes in Hispanic 
adults. The study will focus on Hispanic adults aged 18 to 65 years old with moderate to severe 
persistent asthma living in the Kings and Tulare counties in California. 
Background  
 LEP is defined as “individuals who do not speak English as their primary language and 
who have a limited ability to read, speak, write, or understand English” (Sarkar et al., 2016, p. 
609). As reported by the US Census Bureau in 2010, 9% of the population above the age of five 
years is affected by varying levels of LEP and the number of people with LEP has increased by 
at least 80% between 1990 and 2010 (Schwei et al., 2016). Encounters between providers and 
patients who have LEP is fairly common and essentially one in 13 patients in the US is reported 
to have LEP. Overall, two-thirds of all hospitals and more than 50% of internists reportedly 
interact with a patient who has LEP at least once a week (Andres, Wynia, Regenstein, & Maul, 
2013). Previous literature has linked the presence of a language barrier with adverse effects on 
health outcomes such as “access to care, health status, use of health services, quality of care, 
patient-physician communication, satisfaction with care, and patient safety” (Flores, 2014, p. 
1261). According to McQuaid (2018), LEP is also associated with socioeconomic disadvantage. 
 Spanish-speakers with LEP have been found to receive lower quality care than their 
English proficient counterparts, contributing to disparities in health care outcomes (Lor, Xiong, 
Schwei, Bowers, & Jacobs, 2016). Out of the 37.6 million Spanish-speakers residing in the US, 
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at least 47% have reported to not being able to communicate in English “very well” (White, 
2015). In Hispanics, LEP has been linked to higher rates of miscommunication, less patient  
satisfaction due to the inability of clinicians to provide patient-centered care, reduced medication 
adherence, and increased medication side effects due to the inability of LEP patients to fully 
understand the proper use of medications (White, 2015). As mandated by Title VI of the Civil 
Rights Act of 1964, all federally funded programs are required by law to implement meaningful 
access to care for patients with LEP (Schwei et al., 2016). In 2000, the US Department of Health 
and Human Services, Office of Minority Health, developed the National Standards for Culturally 
and Linguistically Appropriate Services in Health and Health Care (CLAS Standards) (The 
National CLAS Standards, n.d.). The goal of the CLAS Standards is to promote high quality 
health care and enhance health equity for the increasingly diverse minority groups in the US. The 
CLAS standards were most recently updated in 2013 and include 15 action steps that work as a 
framework to assist clinicians and health care organizations in providing the most culturally and 
linguistically appropriate care to minority patients (The National CLAS Standards, n.d.). Despite 
the provisions put in place by this law, LEP patients continue to receive poor quality health care. 
A major factor contributing to this dilemma is that the meaningful access to care privileges for 
LEP patients have not been extensively advocated within the health care system and many 
providers continue to lack the knowledge of its effectiveness towards improving health outcomes 
(Schwei et al., 2016). Furthermore, when caring for patients with LEP, longer office visit times 
need to be allocated to ensure appropriate translation of health information and to allow for 
complete understanding of information provided, both by the patient and the provider. This 
becomes especially challenging for clinics with high patient loads (McQuaid & Landier, 2017). 
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Research has shown that when compared with English proficient patients, those with LEP are 
often offered fewer healthcare resources, including interpreter services. Other studies have  
reported that when professional interpreter services are utilized for LEP patient visits, healthcare 
providers are often inattentive and not entirely supportive to the needs of their LEP patients 
(McQuaid & Landier, 2017). 
 In Hispanic patients with asthma, effective communication between patient and provider 
has been associated with improvement in the chronic management of asthma symptoms (Carlin, 
Yee, Fagnano, & Halterman, 2014). LEP has also been linked to reduced medication adherence 
in this population. Medication adherence plays a crucial role in the effective, long-term 
management of chronic diseases such as asthma, with a lack of treatment adherence leading to 
reduced asthma outcomes and unnecessary accumulation of healthcare costs (White, 2015). 
McQuaid and Landier (2017), defined adherence as the “extent to which a person’s behavior (in 
terms of taking medications, following diets, or executing other lifestyle changes) coincides with 
the clinical prescription” (p. 200). The process of successful adherence to medication includes 
three phases: initiation, implementation and discontinuation. During the initiation phase, the 
healthcare provider prescribes a medication and provides adequate information regarding the 
benefits and proper use of the medication to the patient and their family. The implementation 
phase involves the patient taking the prescribed medication according to the directions provided 
by their provider. Subsequently, in the discontinuation phase, the patient is expected to complete 
the prescribed course of medication without stopping prematurely (McQuaid & Landier, 2017). 
Low levels of health literacy within the Hispanic population have been associated with reduced 
medication adherence and incorrect use of prescribed medication (Sarkar et al., 2016). The 
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effects of culture are thought to play a pivotal role in how a Hispanic patient perceives the need 
to adhere to their medication regimen (McQuaid, 2018). Previous research has revealed that due  
to differences in sociocultural background, Hispanic patients are more fearful of their healthcare 
providers, are more hesitant to utilize healthcare services for the management of their asthma, 
have higher levels of concern regarding the use of their controller medications, and have lower 
levels of trust in the health care system (Ahmed & Bates, 2017; McQuaid, 2018). A majority of 
Hispanic patients belong to low-income households, have lower levels of education, lack health 
insurance, and do not have a stable healthcare provider, and a place to receive routine care (De 
Jesus & Xiao, 2014). In addition to LEP, these factors hinder their access to health care services 
for the management of persistent asthma.  
Problem Statement 
 It is widely accepted in the literature that LEP leads to significant reductions in health 
outcomes. Improvements in patient-provider communication can lead to increased patient 
satisfaction and better management of chronic illnesses. According to the asthma management 
guidelines developed by the National Heart, Lung and Blood Institute (NHLBI), the 
effectiveness of the communication between a patient and their healthcare provider is one of the 
major factors associated with improved treatment adherence and the chronic management of 
asthma symptoms (Carlin et al., 2014).  
 Although LEP is a prevalent healthcare issue affecting the Hispanic population in the US, 
there remains a continued discrepancy in the data pertaining to its effects on Hispanic adults with 
moderate to severe persistent asthma. As reported by the US Census Bureau, 44% of Spanish-
speakers were found to have some level of LEP in 2010 (Riera et al., 2015). With the continued 
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growth observed in the Hispanic population, it is imperative that further research be conducted to 
reduce the current gaps in the literature, and assist clinicians in providing effective, high quality, 
culturally competent, and satisfactory care that will relieve the current burdens of asthma 
management faced by this under-studied group (Sofianou et al., 2012).  
Purpose 
 There are discrepancies in the current literature regarding the adverse effects of LEP in 
Hispanic adults with moderate to severe persistent asthma. With the Hispanic population steadily 
on the rise, added research is imperatively required to establish effective interventions that will 
advance the future delivery of asthma care and diminish the barriers imposed by the presence of 
LEP (Schwei et al., 2016). The intent of this research study, therefore, is to determine if the 
presence of LEP is associated with medication adherence behaviors and adverse asthma 
outcomes in Hispanic adults aged 18 to 65 years old with moderate to severe persistent asthma, 
living in the Tulare and Kings counties of California. 
Theoretical model 
 The Purnell Model for Cultural Competence was developed by Larry Purnell in 1995 
(Purnell, 2019). This model will be used as the theoretical and conceptual framework for this 
project. It will serve as a structural guide during the research study to highlight the influence of 
the Hispanic culture on adult patients with LEP. This includes the effect of cultural beliefs on 
patients’ perception of asthma, adherence to asthma medications, and their level of satisfaction 
with asthma outcomes. For the past 20 years, the Purnell model has been used extensively in 
both the healthcare and various other professional settings to promote culturally competent and 
culturally congruent care. While proving its effectiveness as a guide to promote cultural 
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competence, the Purnell model has also proved useful in other analogous areas of healthcare 
such as language interpretation and documentation translation (Butts & Rich, 2018; Purnell, 
2019). Within the model, there are 12 different domains that form the organizing framework 
(Purnell, 2019). The Communication domain, especially, relates to the concepts of “dominant 
language, health literacy, paralanguage variations, and use of nonverbal communications” (Butts 
& Rich, 2018, p. 580). In addition to its usefulness in providing culturally competent care to 
Hispanic patients with LEP, the assumptions of the Purnell model closely align with the intention 
of this study. These assumptions, specifically, include:  
 (a) if patients are coparticipants in their care and have a choice in health- related goals,  
 plans, and interventions, their compliance and health outcomes will be improved; (b)  
 culture has a powerful influence on one’s interpretation of and responses to health care;  
 (c) caregivers who assess, plan, intervene, and evaluate in a culturally competent manner  
 will improve the care of patients for whom they care; and (d) to be effective, health care  
 must reflect the unique understanding of the values, beliefs, attitudes, lifeways, and  
 worldviews of diverse populations and individual acculturation patterns. (Purnell, 2019,  
 p. 98-100) 
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CHAPTER 2: LITERATURE REVIEW 
Review of the Literature 
 An extensive review of literature was conducted on the adverse effects of LEP on asthma 
outcomes and medication adherence in adult Hispanics of the Kings and Tulare counties in 
California. The California State University, Fresno’s online research database [Henry Madden 
Library] was used to conduct an online search for related research articles. A combination of key 
words and phrases used to search for relevant articles included: asthma; California; Tulare 
county; Kings county; Hispanic; Hispanic adult; limited English proficiency; LEP; health 
literacy; persistent asthma; and moderate and severe persistent asthma. 
 1. Apter et al. (2013) conducted a study to assess the relationship between health literacy 
and subsequent asthma self-management, as measured by adherence to inhaled corticosteroids 
(ICS) and asthma outcomes. This study was designed as a prospective longitudinal cohort study 
within a large randomized controlled trial. It consisted of 284 adults, aged 34-62 years old, with 
moderate or severe persistent asthma who either spoke English or Spanish as their primary 
language. The participants were recruited from practices located in low-income, inner city 
neighborhoods throughout Pennsylvania and Philadelphia, with a high prevalence of asthma 
morbidity. An initial study was conducted to compare individual problem-solving strategies to 
standard asthma education. Subsequently, in a 26-week trial, data was collected to electronically 
monitor adherence and asthma clinical outcomes, including variables for asthma control, asthma 
related quality of life, and Forced Expiratory Volume in one second [FEV1] (Apter et al., 2013). 
There was no difference in outcome noted within the randomized groups. Six months later, a 
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secondary assessment was performed using the randomized assignment of literacy 
questionnaires. These results were used to analyze the relationship between adherence and  
asthma outcomes. Health literacy was measured by the means of an asthma-related numeracy 
and reading comprehension, or by using print literacy. An evaluation was then conducted to 
explore whether participants would benefit from the individual problem solving strategy 
intervention by literacy level, and whether the negative association between low literacy levels 
and adherence and asthma outcomes would become reduced through the use of individual 
problem solving strategies. Findings from this study concluded that interventions aimed to 
address the literacy needs of patients may improve asthma outcomes. Furthermore, in order to 
achieve better asthma outcomes, healthcare providers were recommended to consider the health 
literacy level of their patients. The longitudinal design of this study added to its overall strength 
while the five month duration of the study proved to be a limitation (Apter et al., 2013). 
 2. Riera et al. (2014) conducted a qualitative study to explore how asthma health 
communication and asthma action plan delivery are perceived and experienced by LEP 
caregivers. The study consisted of 20 Latino asthma health caregivers with LEP who provided 
regular asthma care to children 2-12 years old in New Haven, Connecticut. While all the 
participants had similar demographic characteristics, individuals both with and without an 
asthma action plan were included in the study. Data was gathered over a period of eight months 
using qualitative, semi-structured, one-to-one, and in-depth interviews in Spanish. The data was 
then systematically analyzed using the constant comparative method. Data triangulation was 
subsequently performed via a qualitative focus discussion group. A grounded theory approach 
was used to code and analyze the data (Riera et al., 2014). The findings of the study concluded 
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that Hispanic LEP caregivers encountered significant burdens associated with their children’s 
asthma management, and experienced frequent ineffective communication with their healthcare  
providers. The researchers recommended effective communication, empathetic communication 
strategies, comprehensive action plans, and improvement in the availability of educational 
opportunities for Hispanic patients with LEP as possible solutions. The inclusion of various 
ethnic sub-groups from both ambulatory and acute care settings was the key strength of this 
study while adoption of a community-based approach limited its generalizability to similar 
populations from different geographical locations (Riera et al., 2014). 
 3. Carlin et al. (2014) conducted a research study to assess the influence of Hispanic 
ethnicity on parent-provider communication, and the level of caregiver confidence in 
communicating with their child’s healthcare provider during an office visit. The data for this 
research was obtained from a larger study, The Prompting Asthma Intervention in Rochester-
Uniting Parents and Providers (PAIR-UP) RTC in Rochester, New York. One hundred and sixty-
six caregivers of children aged 2-12 years old with persistent or poorly controlled asthma were 
recruited to complete surveys in 12 urban primary care offices. Hispanic ethnicity was 
determined through self-report by asking the caregivers whether they considered themselves to 
be Spanish, Hispanic, or Latino. Data was collected both in English and Spanish, initially at the 
office visit and then two weeks later over the phone. During the phone survey, each caregiver 
was asked to provide their perception of their communication with the provider, their degree of 
satisfaction, and their overall confidence in their ability to communicate with the healthcare 
provider. Findings from the study showed that overall, most caregivers found their interaction 
with their providers to be a positive experience. It was concluded that Hispanic caregivers may 
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experience better parent-provider communication than non-Hispanic caregivers. The major 
strength of this study was the ability of the researchers to obtain the parents’ perception of their  
communication with the provider within a two week period, as this reduced the possibility of a 
recall bias. The major weakness of the study was its small sample size which may have limited 
the power to detect a difference in overall data (Carlin et al., 2014). 
 4. Sarkar et al. (2016) sought to determine how health care outcomes were affected by 
varying levels of health literacy and English proficiency present among Hispanic subgroups. The 
study was conducted over a two-month period and consisted of 4,013 nationally recruited 
participants aged 18 years and older. During a phone interview, conducted in either English or 
Spanish, each participant self-reported their level of health literacy via a three-item health 
literacy assessment. The score of this assessment was used to categorize each participant as 
having either “adequate” or “inadequate” health literacy (Sarkar et al., 2016). The language 
proficiency of the participants was assessed using the Pew Hispanic Healthcare report and their 
responses were coded as Spanish speaker, Spanish reader, English speaker, and English reader, 
respectively. Acculturation of the participants was measured using the Pew Hispanic Healthcare 
Survey. Additional information obtained included health outcomes, demographic variables, and 
comorbidity status of the participants. Despite the presence of LEP, a positive correlation was 
noted between health literacy and healthcare outcomes of bilingual and Spanish dominant 
speakers. The study findings revealed that elevated levels of inadequate health literacy exists 
within all Hispanic subgroups (English-dominant, bilingual, and LEP). Additionally, across all 
English proficiency levels, individuals with higher levels of health literacy were more likely to 
report increased levels of healthcare satisfaction when compared to those with lower levels of 
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health literacy. This study concluded that Hispanic patients with higher levels of health literacy 
were less likely to utilize traditional methods of health care treatment when compared to  
Hispanics with lower levels of health literacy. Due to the large number of nationally recruited 
participants, the findings of this study could be generalized to the Hispanic population across the 
US. The assessment of health literacy via participant self-report was noted as one of the 
limitations of this study (Sarkar et al., 2016). 
 5. Soones et al. (2016) sought to “describe the causal pathway linking health literacy to 
medication adherence by modeling asthma illness and medication beliefs as mediators” (p. 804). 
The data for this research was adopted from the Asthma Beliefs and Literacy in the Elderly 
study. The study consisted of 433 participants, aged 60 years and older, who were either English 
or Spanish speaking, and had moderate to severe persistent asthma. The participants were 
recruited from the hospital and community-based primary and pulmonary care clinics in New 
York and Chicago from December 2009 to May 2012. In-person interviews were conducted in 
either English or Spanish to obtain information regarding the socioeconomic characteristics of 
each participant. Health literacy was assessed using the Short Test of Function Health Literacy in 
Adults (S-TOFHLA) and scores were categorized as having either adequate or limited health 
literacy. Participants’ beliefs regarding asthma and medications were assessed with the Belief 
Illness Perceptions Questionnaire (B-IPQ). Cognitive function in older participants was assessed 
using tests from the Alzheimer’s Disease Centers’ Uniform Data Set. Medication adherence in 
participants was measured using the Medication Adherence Rating Scale (MARS) (Soones et al., 
2016). The findings of this study concluded that the correlation between limited health literacy 
and low adherence to asthma controller medication was partially associated with beliefs about 
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medications. The researchers recommended that improved asthma outcomes could be achieved if 
healthcare providers paid attention to patients’ concerns regarding medication beliefs and used  
simplified language when caring for patients with low health literacy levels and cognitive 
impairment. The key strength of this study was the use of a the structural equation model to 
determine the relationship between health literacy, illness, and medication beliefs, and cognitive 
function and medication adherence. The findings of this study were limited by its lack of 
generalizability to younger individuals with moderate to severe persistent asthma, and by the 
exclusion of individuals living in rural areas (Soones et al., 2016). 
 6. In light of the rapidly increasing Latino population in the US, Bohm and Cupertino 
(2014) conducted a study of rural hospitals to determine the language accommodation methods 
utilized by these hospitals when providing care for their patients. According to Title VI of the 
Civil Rights Act of 1964 and the CLAS Standards, the provision of language access services for 
patients with LEP is federally mandated. Rural hospitals, due to their lack of resources, are 
mostly challenged when having to provide language translation services for their Spanish-
speaking patients (Bohm & Cupertino, 2014). A ten-item survey was constructed by the 
researchers and mailed out to 153 rural hospitals in Kansas and Missouri. The survey included 
information regarding the monthly volume of LEP Spanish-speakers at each hospital. These 
hospitals were inquired about their use of translated documents such as “advertisement of 
language services, educational material, consent forms, complaint forms, preparation information 
for procedures and diagnostic tests, and discharge instructions” (Bohm & Cupertino, 2014, p. 
1278). Each hospital was asked about their interpretation methods including “bilingual family 
members, clinical bilingual staff, non-clinical bilingual staff, staff interpreters, contract 
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interpreters, telephonic interpreters, or volunteer interpreters” (Bohm & Cupertino, 2014, p. 
1278). The participants were asked to rate their hospital on a 1-10 scale based upon how well  
they believed care was being provided to the Spanish-speaking patients. The remainder of the 
survey consisted of open-ended questions about any contemporary strategies or obstacles faced 
by each hospital in their care of LEP patients (Bohm & Cupertino, 2014). Results of the survey 
indicated that most rural hospitals treated approximately 0-5 LEP patients each month. Nearly 
71% of the hospitals surveyed used at least one type of translated document, although the 
hospitals that reported a higher volume of LEP patients were not equipped with forms in Spanish 
for preparation procedures and diagnostic tests, discharge instructions, and patient consent. 
According to reports, telephonic interpretation, usage of bilingual family members, and usage of 
bilingual hospital employees were the three major types of interpretation techniques used by 
hospitals, in descending order. The hospitals that treated an extensive number of LEP patients 
generally rated themselves higher on the rating scale. Some examples of barriers reported 
included a small Latino population, lack of financial resources and availability of bilingual 
employees, difficulty providing interpretation services outside business hours, and lack of 
understanding of the Latino culture, etc. (Bohm & Cupertino, 2014). The limitations of this study 
included a small sample size and self-reported measures to obtain participant information. Based 
on the findings, it was concluded that although rural hospitals are modifying their treatment 
strategies to accommodate Hispanic patients with LEP, their care provisions remain suboptimal 
and continued improvement is necessary to fully comply with the CLAS standards. Furthermore, 
hospitals are encouraged to discontinue their use of bilingual family members as interpreters, 
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since the likelihood of untrained interpreters to leave out important information or misinterpret 
information has been made evident in the literature (Bohm & Cupertino, 2014). 
 7. Although previous literature supports the fact that patient-provider communication is 
associated with improved adherence to asthma medications, the definitive understanding of this 
communication pathway remains unclear. Young et al. (2016) conducted a cross-sectional survey 
study to determine the nuances of the communication pathway that lead to enhancement in 
patients’ use of their asthma medications. The survey was designed categorically to assess 
“patient-provider communication, proximal outcomes, medication adherence, and demographic 
characteristics” (Young et al., 2016, p. 697). The participants of the study (n = 452) were 
recruited through an online survey delivery and participant recruitment service. The participants 
were permitted eligibility to complete the survey if they reported to be more than 18 years old, 
were clinically diagnosed with asthma, and were prescribed a preventative or rescue medication 
for asthma within the past year. The findings of the study concluded that while there was a 
positive and direct link between patient-provider communication and “patients’ understanding of 
asthma self-management, agreement with providers, trust, involvement in care, and motivation”, 
there was a positive but indirect link between patient-provider communication and adherence to 
asthma medication (Young et al., 2016, p. 700). Among the findings of the study, disparities in 
asthma self-management were noted in patients from different racial/ethnic groups and 
educational levels. The Hispanic/Latino patients, mainly, were found to have decreased levels of 
asthma self-management knowledge when compared to their Caucasian counterparts. 
Furthermore, Hispanic patients with a high school diploma were found to be less knowledgeable 
than those with a college degree. The effects of race/ethnicity and educational level on the self-
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management of asthma were found to be prominent factors leading to long-term disparities in 
patients’ asthma outcomes. While “written action plans, self-monitoring, and regular medical 
reviews” (Young et al., 2016, p. 700) were some of the interventions proposed by the researchers 
to mitigate the effects of racial and educational variations, additional research has been 
recommended to explore the roles played by culture and primary language spoken by patients 
from different racial/ethnic and educational backgrounds, and their association with asthma self-
management (Young et al., 2016). The major limitations of this study included the use of a cross-
sectional study design and a self-reported survey to gather information from participants. In 
addition, the severity of asthma in each participant was not controlled for and the participants 
were recruited from an online recruitment service. These factors decreased the generalizability of 
the study findings by excluding patients who do not have access to the internet (Young et al., 
2016).   
Gaps in the Literature  
 After extensive review of the effects of LEP on asthma outcomes and medication 
adherence in the Hispanic adults of the Kings and Tulare counties, some essential discrepancies 
were identified in the existing literature. There is limited information available in the current 
literature pertaining to the effects of LEP in adult Hispanics who have moderate to severe 
persistent asthma. Although misdiagnosis and under-treatment of asthma is frequently observed 
in older patients, an exceeding amount of the data available is based either on studies conducted 
on Hispanic children with asthma, or their caregivers who have LEP (Sofianou et al., 2012). A 
majority of these studies focus on Hispanics living in larger cities or urban areas. Thus, their 
findings cannot be generalized to the Hispanic population residing in the rural areas of 
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California. Considering the rapid increase in the Hispanic population in the US, these 
discrepancies in the literature require a compelling need for further research to ensure future 
provision of quality asthma care and improvement in asthma outcomes in this under-studied 
population. Research studies focusing on adult Hispanics with LEP will also contribute towards 
educating healthcare providers about the cultural and health care needs of this population, 
promote medication adherence and self-management of asthma, improve asthma outcomes, and 
enhance effective patient-provider communication. 
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CHAPTER 3: METHODOLOGY 
Participants and Setting 
 This study focuses on the adult Hispanic residents of the Kings and Tulare counties in 
California. The potential participants for this study will be recruited via a convenience sampling 
method from two Baz Allergy, Asthma & Sinus Center clinics located in Hanford and Visalia. 
The potential participants will be identified using information obtained from their electronic 
medical record (EMR). This quantitative pilot study will consist of 50 patients of Hispanic 
descent, aged 18 to 65 years old, with a clinically confirmed diagnosis of moderate or severe 
persistent asthma. One group of 25 participants will be proficient in English while the remaining 
half will have LEP. To be eligible for inclusion in the study, each participant has to be: (a) 
between the ages of 18 to 65 years old; (b) of Hispanic descent; (c) either English or Spanish 
speaking, or bilingual; and (d) have a clinically confirmed diagnosis of moderate or severe 
persistent asthma. Any participant who does not meet this eligibility criteria, has chronic 
obstructive pulmonary disease (COPD) or other chronic pulmonary disease, or has more than a 
10-pack-per-year history of smoking, will be excluded from the study. All participants identified 
for the study will be established patients of the clinic and therefore, be familiar with the staff, 
providers, and the clinic procedure protocols. The potential participants will be approached 
during their office visit and invited to volunteer as participants in the study. Data for this study 
will be collected over a span of 4 months, from October, 2018 to February, 2019. Prior to data 
collection, a consent form, which includes the purpose and protocol of the study, will be 
reviewed in detail with each participant and signed. The English or Spanish version of the 
consent form will be used based on the participants’ language preference (see Appendices A and  
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B). Any individual incapable of providing an in-person written consent for the study due to 
unwillingness or health limitations, will be excluded from participating in the study. Two sets of 
data will be collected from the same participants at three month intervals; the first set from 
October to November, 2018, and the second set from January to February, 2019. The clinic 
where each participant will provide their information will depend on where they had established 
care prior to the study. This location will remain consistent throughout the duration of the study. 
Information will be gathered in either English or Spanish, based on the participants’ language 
preference. For this study, two trained, bilingual medical assistants from each office will be 
assigned to assist with language translation and data collection.  
Measures 
 Information regarding English proficiency, health literacy, sociodemographic 
characteristics, asthma history, and chronic comorbid conditions will be obtained at the initial 
visit. The level of English proficiency, sociodemographic characteristics, and asthma history will 
be obtained verbally through self-report. The level of health literacy of each participant will be 
assessed using the Short Test of Functional Health Literacy in Adults (S-TOFHLA) (Baker, 
Williams, Parker, Gazmararian, & Nurss, 1999; Wisnivesky et al., 2012) (see Appendices C and 
D). Assessments for asthma outcome and medication adherence will be completed at the initial 
visit, and then at a three month interval. Asthma outcome measurements will be assessed with 
the Asthma Control Questionnaire (ACQ) (Juniper, 2004; Wisnivesky et al., 2012) (see 
Appendices E and F) and the Asthma Quality of Life Questionnaire (AQLQ) (Juniper, 1991; 
Wisnivesky et al., 2012) (see Appendices G and H). Medication adherence will be assessed using 
the Medication Adherence Rating Scale (MARS) (Thompson, n.d.; Apter et al., 2013; 
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Wisnivesky et al., 2012) (see Appendix I and J). The English or Spanish version of each 
questionnaire will be used, based on the participants’ language preference. For the purpose of 
this study, the consent form and the MARS questionnaire were translated into Spanish by a 
certified language translator. 
English proficiency 
 During the initial visit, each participant will be evaluated for their level of English 
proficiency. Each participant will be asked to verbally categorize their primary language as 
English, Spanish, or both. The participants who report Spanish as their primary language will 
then be asked to classify their ability to speak and understand English as very poor, poor, fair, 
good, very good, or excellent. Participants who rate their ability to speak English as very poor, 
poor, or fair, will be categorized as having LEP. The remaining participants will be classified as 
having English proficiency (EP) (Wisnivesky et al., 2012).  
Asthma outcomes 
 The asthma outcomes for participants will be measured twice using an ACQ and an 
AQLQ. Both of these questionnaires have been previously validated in both English and Spanish 
(Juniper, O’Byrne, Guyatt, Ferrie, & King, 1999; Juniper, Buist, Cox, Ferrie, & King, 1999; 
Wisnivesky et al., 2012). The ACQ is a 7-item questionnaire used to measure asthma control. 
The questionnaire includes questions about the five most important asthma symptoms, the 
frequency of the albuterol inhaler use, and the FEV1% predicted value of the spirometry test. The 
responses gauge the participants’ asthma control over the past week. The final score is the mean 
score of all the responses. A score of 0 is indicative of well-controlled asthma whereas a score of 
6 indicates highly uncontrolled asthma. For the purpose of this study, the optimal cut-point will 
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be 1.50. If a participant’s mean score on the questionnaire is ≥ 1.50, this means that there is an 
88% or higher chance that their asthma is not well-controlled (Juniper, 2004). The AQLQ will be 
used to analyze asthma-related quality of life. The questionnaire has a recall period of two weeks 
and determines the participants’ overall well-being by asking questions about lifestyle issues 
commonly related to asthma. The questionnaire consists of 32 items grouped into 4 categories: 
activity limitations, symptoms, emotional function, and environmental stimuli. Each question has 
a 7-point response scale ranging from 1 (severe impairment) to 7 (no impairment). The final 
score is the mean score of the 32 responses (Juniper, 2010; Apter et al., 2013; Wisnivesky et al., 
2012). For the purpose of this study, a score of 1.0 to 3.0 will be categorized as a severe 
impairment, a score of 3.1 to 5.0 will be categorized as a moderate impairment, and a score of 
5.1 to 7.0 will be categorized as having no impairment on asthma-related quality of life. The 
spirometry testing will be performed according to the recommendations set forth by the 
American Thoracic Society (ATS) to assess lung function (ATS, 2017). Indices for FEV1pre-
bronchodilator, FEV1predicted, and FEV1%predicted will be recorded for each participant 
initially, and then at a three month interval, as part of question number seven of the ACQ 
(Juniper, 2004; Apter et al., 2013; Culver et al., 2017). 
Medication adherence 
 The lack of medication adherence in Hispanic patients with LEP has been associated with 
impaired asthma outcomes (White, 2015). The MARS will be used to assess for controller 
medication adherence in participants (Thompson, n.d.). As part of this study, asthma controller 
medications will consist of inhaled corticosteroids (ICS), long-acting beta agonists (LABA), 
long-acting muscarinic antagonists (LAMA), and leukotriene receptor modifiers. MARS is a 
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validated measuring scale consisting of 10 items used to assess for medication adherence. Each 
of the 10 items will be scored based on a 5-point Likert Scale where higher scores are indicative 
of better medication adherence (Thompson, Kulkarni, & Sergejew,  
2000; Wisnivesky et al., 2012, p. 180). For the purpose of this study, the participants with a total 
score of ≥ 5 will be categorized as being compliant with medication adherence and those with a 
score of ≤ 5 will be categorized as being non-compliant. 
Covariates 
Health literacy 
 Previous research has confirmed that elevated levels of inadequate health literacy does 
have an association with adverse asthma outcomes and decreased medication adherence (Apter et 
al., 2013; Sarkar et al., 2016; Wisnivesky et al., 2012). The S-TOFHLA will be used to measure 
the level of health literacy in the participants (Nurss, Parker, Williams & Baker, 2001). This tool 
has been previously validated for use in research and is available in both English and Spanish 
(Baker et al., 1999). The S-TOFHLA consists of 36-items, with the final score being the total 
number of items that were answered correctly (Apter et al., 2013; Wisnivesky et al., 2012). For 
the purpose of this study, the participants with a score of 0 to 16 will be identified as having 
inadequate functional health literacy. The participants with scores between 17 to 22 will be 
placed in the marginal functional health literacy category, and those with a score of 23 to 36 will 
be categorized as having adequate functional health literacy (Nurss et al., 2001). 
Alternative variables 
 The data on alternative variables will be collected via self-report as part of the 
participants’ baseline characteristics at the initial visit. These will include sociodemographic 
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information (age, sex, annual income, and the level of education), asthma history (the number of 
years since diagnosis of asthma, history of intubation, current oral steroid dependency, and recent 
treatment with oral steroids), and other chronic health conditions (allergy, eczema, sinusitis, 
gastroesophageal reflux disease (GERD), diabetes, hypertension, 
congestive heart failure (CHF), osteoporosis, and obesity) (Sarkar et al., 2016; Soones et al., 
2016; Wisnivesky et al., 2012). The raw data will be coded and categorized prior to statistical 
analysis. The age of the participants will be categorized in years as: 18-29; 30-39; 40-49; 50-59; 
and 60-65. The sex of the participants will be categorized as: male; female. The annual income 
of the participants will be categorized as: ≤ $20,000; $20,000-$34,999; $35,000-$49,999; 
$50,000-$74,999; $75,000-$99,999; and ≥ $100,000. The level of education will be categorized 
as: ≤ high school; high school or equivalent; some college, no degree; associates degree; 
bachelor’s degree; master’s degree; and doctoral degree. The number of years since the diagnosis 
of moderate or severe persistent asthma will be categorized into years as: 0-5; 6-10; and ≥ 11yrs. 
Statistical Analysis 
 The data obtained during this study will be analyzed using the SPSS® Statistics, Version 
24.0 software. A descriptive correlational analysis using the chi-square test will be used to 
interpret the relationship between the categorical variables. A frequency distribution statistics test 
will be used to identify the occurrence of values within the various test intervals. The  
aim of the statistical analysis will be to identify if there is a statistically significant correlation 
between the level of English proficiency, asthma outcome (asthma control and asthma quality of 
life) and the medication adherence variables. The covariate variables (health literacy, 
sociodemographic variables, asthma history, and chronic comorbidities) will also be compared 
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with the level of English proficiency to assess for the existence of a significant correlation 
between the variables. A statistically significant relationship between the variables will be 
confirmed based on a p-value of ≤ 0.05 (Knapp, 2017). 
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CHAPTER 4: RESULTS 
Baseline Population Characteristics 
 From October to November 2018, 37 patients were recruited to participate in the research 
study from the Baz Allergy, Asthma & Sinus Center clinics located in Hanford and Visalia, 
California. Twenty-five of the participants were English-proficient, while the remaining 12 had 
LEP. These participants were identified for the study based on the clinics’ EMR database. 
Participants were approached for consent to participate in the study if they were (a) between the 
ages of 18 to 65 years old; (b) of Hispanic descent; (c) either spoke English, Spanish, or both; 
and (d) had a clinically confirmed diagnosis of moderate or severe persistent asthma. While 
reviewing patients EMR information, the patients who were of non-Hispanic descent, outside 18 
to 65 years of age, had COPD or other chronic pulmonary disease, and had more than a 10 pack-
per-year history of smoking, were excluded. The SPSS® Statistics, Version 24.0 software was 
used to conduct statistical analyses on the data collected. The aim of the research study, initially, 
was to collect two sets of data on the participants, with an interval of three months in between. 
The data was scheduled to be collected from October to November of 2018 (Round 1) and then 
from January to February of 2019 (Round 2). Due to unforeseen time constraints, only one set of 
data, from October to November of 2018, was successfully gathered. The second round of 
collection was attempted in January of 2019 but not enough data could be compiled to conduct a 
meaningfully significant statistical analysis.  
 Table 1 includes the baseline characteristics of all participants enrolled in the study based 
on their level of English proficiency. The variables for the baseline population characteristics 
included sociodemographic characteristics (age, gender, annual income, and the highest level of  
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Table 1 
Baseline Characteristics of Participants Associated with English Proficiency 
Note. EP - English Proficient; LEP - limited English proficiency. n - sample size. * - significant p-value (p ≤ 0.05). 
Characteristic Total (%) 
(n=37)
EP (%) 
(n=25)
LEP (%) 
(n=12)
p-value
Age, years (%) 
   18-29 
   30-39 
   40-49 
   50-59 
   60-65
4 (10.8) 
9 (24.3) 
6 (16.2) 
9 (24.3) 
9 (24.3)
4 (16.0) 
8 (32.0) 
4 (16.0) 
5 (20.0) 
4 (16.0)
0 (0.0) 
1 (8.3) 
2 (16.7) 
4 (33.3) 
5 (41.7)
0.092
Sex (%) 
   Male 
   Female
12 (32.4) 
25 (67.6)
9 (36.0) 
16 (64.0)
3 (25.0) 
9 (75.0)
0.711
Annual income (%) 
   ≤ $20,000 
   $20,000-$34,999 
   $35,000-$49,999 
   $50,000-$74,999 
   $75,000-$99,999 
   ≥ $100,000
19 (55.9) 
2 (5.9) 
3 (8.8) 
7 (20.6) 
2 (5.9) 
1 (2.9)
8 (36.4) 
2 (9.1) 
2 (9.1) 
7 (31.8) 
2 (9.1) 
1 (4.5)
11 (91.7) 
0 (0.0) 
1 (8.3) 
0 (0.0) 
0 (0.0) 
0 (0.0)
0.013*
Education (%) 
   ≤ High school  
   High school or equivalent 
   Some college, no degree 
   Associates degree 
   Bachelor’s degree 
   Master’s degree 
   Doctoral degree
13 (35.1) 
6 (16.2) 
10 (27.0) 
3 (8.1) 
3 (8.1) 
2 (5.4) 
0 (0.0)
2 (8.0) 
5 (20.0) 
10 (40.0) 
3 (12.0) 
3 (12.0) 
2 (8.0) 
0 (0.0)
11 (91.7) 
1 (8.3) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0)
0.000*
Asthma history (%) 
   Ever intubated 
   Steroid dependent 
   Oral steroid treatment within 3 months 
Years with asthma (%): 
      0-5 yrs 
      6-10 yrs 
      ≥ 11yrs
0 (0.0) 
0 (0.0) 
6 (16.2) 
11 (29.7) 
9 (24.3) 
17 (45.9)
0 (0.0) 
0 (0.0) 
4 (16.0) 
4 (16.0) 
8 (32.0) 
13 (52.0)
0 (0.0) 
0 (0.0) 
2 (16.7) 
7 (58.3) 
1 (8.3) 
4 (33.3)
N/A 
N/A 
1.000 
0.025* 
Self-reported chronic conditions (%) 
   Allergy 
   Eczema 
   Sinusitis 
   Gastroesophageal reflux disease (GERD) 
   Diabetes 
   Hypertension 
   Congestive heart failure (CHF) 
   Osteoporosis 
   Obesity
37 (100.0) 
5 (13.5) 
2 (5.4) 
13 (35.1) 
8 (21.6) 
11 (29.7) 
0 (0.0) 
0 (0.0) 
27 (73.0)
25 (100.0) 
3 (12.0) 
2 (8.0) 
7 (28.0) 
3 (12.0) 
5 (20.0) 
0 (0.0) 
0 (0.0) 
18 (72.0)
12 (100.0) 
2 (16.7) 
0 (0.0) 
6 (50.0) 
5 (41.7) 
6 (50.0) 
0 (0.0) 
0 (0.0) 
9 (75.0)
N/A 
1.000 
1.000 
0.274 
0.083 
0.122 
N/A 
N/A 
1.000
Health literacy (%) 
  Inadequate functional health literacy 
  Marginal functional health literacy 
  Adequate functional health literacy
7 (18.9) 
2 (5.4) 
28 (75.7)
1 (4.0) 
1 (4.0) 
23 (92.0)
6 (50.0) 
1 (8.3) 
5 (41.7)
0.003*
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education), asthma history (history of intubation, current oral steroid dependence, history of oral 
steroid exposure within the past three months, and the number of years with asthma), and the 
level of functional health literacy. A frequency distribution statistics test was used to measure the 
occurrence of the baseline characteristic variables within the overall population, based on the 
level of English proficiency. The chi-square test was used to determine if a significant correlation 
existed between the categorical variables of the baseline characteristics and the level of English 
proficiency. If the test between two variables did not meet the chi-square pre-test criteria (1 - n ≥ 
5 per cell minimum) (Knapp, 2017), the Pearson’s chi-square coefficient was not used to 
determine the significance of the relationship between the variables. In this case, the Fisher’s 
exact test coefficient was used if the 2 x 2 table criteria was met. If the test failed to meet the 
criteria for both the chi-square test and the Fisher’s exact test, then the likelihood ratio was used 
to analyze the relationship between the variables (Knapp, 2017).  
 In the EP group, a majority of the patients were between the ages of 30 to 39 years old 
(32%) while in the LEP group, most patients were between the ages of 50 to 65 years old (75%). 
There were more female participants in the study compared to males; 64% of the participants in 
the EP group and 75% of those in the LEP group were female. There was no significant 
relationship between the age and gender of the participants and their level of English proficiency 
(p-value 0.09 and 0.71, respectively). Overall, nearly 56% of the participant population earned ≤ 
$20,000 per year. Within both the EP and LEP groups, the majority of the participants earned less 
than $20,000 annually. For the EP group, the second-highest income range was between 
$50,000-$74,999 while in the LEP group, the second-highest income range was seen in the 
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$35,000-$49,999 range. Three of the 37 participants failed to provide data about their annual 
income. A significant correlation was seen between the annual income earned and the level of 
English proficiency (p-value 0.01). A majority of the overall population reported having an 
education level that was either less than a high school degree or with some college education, but 
no degree. For the EP group, 40% of the participants had some college education with no degree, 
while 91.7% of the LEP group had a ≤ high school education. A significant relationship was 
noted between the participants’ level of education and English proficiency. None of the 
participants were steroid dependent or had a history of ever being intubated during an asthma 
flare. A similar frequency of oral steroid use was observed for both the EP and the LEP groups 
over a period of three months. Overall, nearly 46% of the participants reported having asthma for 
≥ 11 years. While 52% of the participants in the EP group reported having asthma for ≥ 11 years, 
more than half (58%) of the patients in the LEP group reported a fairly recent diagnosis of 
asthma (0-5 years). A significant correlation was observed between the years since the diagnosis 
of asthma and the English proficiency level (p-value 0.03) of the participants. No correlation was 
noted in the participants’ self-reported chronic comorbidities and their level of English 
proficiency. Overall, 73% of the participants were obese; 72% of the EP group was obese while 
75% of the LEP participants had a Body Mass Index (BMI) that fell in the obesity range. A 
distinct correlation was noted between the level of health literacy and the level of English 
proficiency (p-value 0.03). Overall, a majority of the patient population had adequate functional 
health literacy (~76%). Within the EP group, 92% of the patients had adequate functional health 
literacy while half of the LEP group, had inadequate functional health literacy. 
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Table 2 
Association of Major Covariates with Asthma Outcomes and Medication Adherence 
Note. AC - Asthma Control, WC - well controlled, NWC - not well controlled. QoL - Quality of Life, Mi - mild 
impairment, Mo - moderate impairment, Se - severe impairment. MA - Medication Adherence; C - compliant, NC - 
non-compliant. n - sample size. FHL - functional health literacy. * - n = 34 (3 participant responses missing for 
annual income), ** - significant p-value with p ≤ 0.05. 
Covariates 
 The baseline population characteristic variables, annual income, level of education, the 
number of years with asthma, and health literacy, were noted to have a significant relationship 
with the level of English proficiency (p-value ≤ 0.05) (Table 1). These were considered to be the  
Outcome AC (%) 
(n=37) 
   WC            NWC              
QoL (%) 
(n=37) 
    Mi             Mo           Se
MA (%) 
(n=37) 
     C           NC
Annual income (%) * 
   ≤ $20,000 
   $20,000-$34,999 
   $35,000-$49,999 
   $50,000-$74,999 
   $75,000-$99,999 
   ≥ $100,000 
p-vale
8 (42.1)        11 (57.9) 
2 (100.0)      0 (0.00) 
2 (66.7)        1 (33.3) 
5 (71.4)        2 (28.6) 
2 (100.0)      0 (0.00) 
1 (100.0)      0 (0.00) 
0.156
  
6 (31.6)      9 (47.4)      4 (21.1) 
0 (0.00)      0 (0.00)      2 (100.0) 
1 (33.3)      1 (33.3)      1 (33.3) 
2 (28.6)      1 (14.3)      4 (57.1) 
0 (0.00)      0 (0.00)      2 (100.0) 
0 (0.00)      0 (0.00)      1 (100.0) 
0.179
15 (78.9)   4 (21.1) 
2 (100.0)   0 (0.00) 
3 (100.0)   0 (0.00) 
7 (100.0)   0 (0.00) 
1 (50.0)     1 (50.0) 
1 (100.0)   0 (0.00) 
0.300
Education (%) 
   ≤ High school  
   High school or equivalent 
   Some college, no degree 
   Associates degree 
   Bachelor’s degree 
   Master’s degree 
   Doctoral degree 
p-value
6 (46.2)        7 (53.8) 
3 (50.0)        3 (50.0) 
6 (60.0)        4 (40.0) 
2 (66.7)        1 (33.3) 
2 (66.7)        1(33.3) 
2 (100.0)      0 (0.00) 
0 (0.00)        0 (0.00) 
0.661
5 (38.5)       5 (38.5)      3 (23.1) 
2 (33.3)       2 (33.3)      2 (33.3) 
2 (20.0)       3 (30.0)      5 (50.0) 
1 (33.3)       0 (0.00)      2 (66.7) 
0 (0.00)       2 (66.7)      1 (33.3) 
0 (0.00)       0 (0.00)      2 (100.0) 
0 (0.00)       0 (0.00)      0 (0.00) 
0.361
10 (76.9)   3 (23.1) 
5 (83.3)     1 (16.7) 
9 (90.0)     1 (10.0) 
3 (100.0)   0 (0.00) 
3 (100.0)   0 (0.00) 
1 (50.0)     1 (50.0) 
0 (0.00)     0 (0.00) 
0.539
Years with asthma: 
   0-5 yrs 
   6-10 yrs 
   ≥ 11 yrs 
p-value
7 (63.6)        4 (36.4) 
6 (66.7)        3 (33.3) 
8 (47.1)        9 (52.9) 
0.541
1 (9.10)       3 (27.3)       7 (63.6) 
1 (11.1)       3 (33.3)       5 (55.6) 
8 (47.1)       6 (35.3)       3 (17.6) 
0.049**
7 (63.6)      4 (36.4) 
8 (88.9)      1 (11.1) 
16 (94.1)    1 (5.90) 
0.106
Health literacy (%) 
  Inadequate FHL 
  Marginal FHL 
  Adequate FHL 
p-value
5 (71.4)         2 (28.6) 
0 (0.00)         2 (100.0) 
16 (57.1)      12 (42.9) 
0.136
2 (28.6)        3 (42.9)     2 (28.6) 
1 (50.0)        1 (50.0)     0 (0.00) 
7 (25.0)        8 (28.6)     13 (46.4) 
0.558
6 (85.7)      1 (14.3) 
1 (50.0)      1 (50.0) 
24 (85.7)    4 (14.3) 
0.517
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major covariates of the study. Table 2 conveys the association of these covariates with the asthma 
outcomes (asthma control and asthma quality of life) and medication adherence. These 
comparisons were conducted to verify if, in addition to having a significant relationship with the 
participants’ level of English proficiency, these baseline characteristics also demonstrated any 
notable relationship with their asthma outcomes and medication adherence. The chi-square test 
was used to determine if a significant correlation existed when these covariates were compared 
with the asthma outcomes and medication adherence variables. As mentioned previously, when 
the test failed to comply with the criteria for both the chi-square test and the Fisher’s exact test, 
the likelihood ratio was used to interpret the relationship between the variables. 
 There was no significant correlation noted when the annual income was compared with 
the participants’ asthma control, quality of life, and medication adherence. Similarly, the levels of 
education and functional health literacy did not demonstrate any significant difference when 
compared to asthma outcomes and medication adherence. In both these comparisons, the p-value 
was ≥ 0.05, which was indicative of no statistically significant difference between the levels of 
these covariates, asthma outcomes and medication adherence. The number of years each 
participant had asthma was compared with asthma outcomes and medication adherence. No 
significant difference was observed between the number of years with asthma when compared to 
asthma control and medication adherence (p-value ≥ 0.05). A p-value of ≤ 0.05 was noted when 
the number of years with asthma was compared with the participants’ quality of life. A majority 
of the participants (~46%) reported having asthma for ≥ 11 years. Most of the participants 
(~41%) reported that asthma severely impaired their quality of life. For the 20 participants who 
reported having asthma for ≤ 10 years, the majority (60%) felt that their asthma severely  
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impaired their quality of life. In the remaining 17 participants who reported having asthma for ≥ 
11 years, the majority (47%) felt that asthma caused a mild impairment to their quality of life. 
English Proficiency, Medication Adherence and Asthma Outcomes 
 The goal of this study was to determine if the presence of LEP affected asthma outcomes 
(asthma control and quality of life) and medication adherence in Hispanic adults with moderate 
to severe persistent asthma. The chi-square test was used to determine if asthma outcomes 
(asthma control and quality of life) and medication adherence had a significant relationship to the 
level of English proficiency of the participants (Table 3). The likelihood ratio was used to 
determine the relationship between the variables if the tests failed to satisfy the criteria 
requirements for both the chi-square and the Fisher’s exact tests. 
Table 3 
Association of English Proficiency with Asthma Outcomes and Medication Adherence 
Note. EP - English proficient, LEP - limited English proficiency. n - sample size. 
 The majority of the participants in both the EP and LEP groups were found to have well 
controlled asthma and reported adequate compliance with their medications. Forty-eight percent 
of the participants in the EP group reported a severe impairment to their quality of life due to 
asthma while only 25% of the LEP group felt this way. In the LEP group, ~42% of the 
Outcome EP (%) 
(n=25)
LEP (%) 
(n=12)
p-value
Asthma control (%) 
   Well-controlled 
   Not well-1controlled
14 (56.0) 
11 (44.0)
7 (58.3) 
5 (41.7)
1.000
Quality of life (%) 
   Mild impairment 
   Moderate impairment 
   Severe impairment
6 (24.0) 
7 (28.0) 
12 (48.0)
4 (33.3) 
5 (41.7) 
3 (25.0)
0.396
Medication adherence (%) 
   Compliant 
   Non-compliant
21 (84.0) 
4 (16.0)
10 (83.3) 
2 (16.7)
1.000
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participants reported moderate impairment and 33% reported a mild impairment to their quality 
of life due to asthma. The percentages of participants who reported mild and moderate 
impairments to their quality of life due to asthma were essentially comparable within the EP 
group. The p-value for the comparisons of asthma control, quality of life, and medication 
adherence were all ≥ 0.05. Therefore, it was concluded that there was no statistically significant 
difference in asthma outcomes and medication adherence behaviors among the participants in 
this study based on the level of their English proficiency.  
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CHAPTER 5: DISCUSSION AND CONCLUSION 
Discussion 
 There is considerable data available in the literature linking LEP to reduced health 
outcomes. These include but are not limited to decreased access to health care resources, 
misunderstanding of medical information and disease process, poor self-management of chronic 
illness, medication non-adherence, and subsequent dissatisfaction and mistrust in the health care 
system (Schwei et al., 2016; Wisnivesky et al., 2012). In the US, the Hispanic population is a 
predominant subgroup that is largely affected by LEP, leading to suboptimal health outcomes 
(White, 2015). In Hispanic adults with asthma, the presence of LEP hinders optimal asthma 
control and the appropriate use of controller medications caused by miscommunication between 
patients and their clinicians (Wisnivesky et al., 2012). As the Hispanic population continues to 
grow, there is a compelling need to focus on the existing gaps in the literature and find competent 
solutions that will promote asthma outcomes and mitigate the health care burden associated with 
LEP. The intent of this study was to explore if the presence of LEP was associated with adverse 
asthma outcomes and medication adherence behaviors in Hispanic adults aged 18 to 65 years old 
residing in the Kings and Tulare counties of California.  
Association of LEP with asthma outcomes and medication adherence 
 Contrary to previous literature, the findings of this study did not indicate a statistically 
significant difference in asthma outcomes (asthma control, quality of life) and medication 
adherence in the presence of LEP. Sarkar et al. (2016) reported a significant positive correlation 
in health outcomes regardless of the presence of LEP. This finding was concluded from a much 
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larger study consisting of over 4,000 nationally recruited participants from various Hispanic 
subgroups. In our study, the reports 
of asthma control were essentially analogous in both the English proficient (EP) and the LEP 
groups (p-value 1.0). A majority of the participants in the EP group described their asthma as 
severely impairing their quality of life (48%) while those in the LEP group reported mild to 
moderate impairment of their quality of life due to asthma (p-value 0.39). Our study was also 
conducted on a much smaller scale which may have restricted its power to identify a significant 
discrepancy in the overall participant data. In 2013, Andres et al. reported that insufficient and 
erroneous communication can lead to severe health implications for LEP patients. Bohm and 
Cupertino (2014) performed a study to explore the language accommodation approaches 
practiced by rural hospitals when providing care for patients with LEP. The results of this study 
concluded that although adjustments are under way to implement higher quality care for LEP 
patients in rural settings, continued efforts are essential to conform to CLAS standards 
requirements, and adequately accommodate the increasing healthcare demands of the Hispanic 
population. The findings of our study, on the contrary, did not exhibit a statistically significant 
discrepancy in the asthma outcomes and medication adherence patterns of the EP and LEP 
groups and thus, did not necessitate any further enhancement of the clinics’ pre-established 
language accommodation parameters. 
 Self-management is a fundamental factor in long term asthma control (Wisnivesky et al., 
2012). In LEP patients with asthma, language barriers hinder access to high quality care, reduce 
effective communication with providers, lessen the capability to adhere to prescribed medication, 
and discourage the self-management of asthma (Andres et al., 2013; Wisnivesky et al., 2012). 
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Riera et al. (2014), explored how asthma communication and action plan delivery were 
perceived and experienced by Hispanic LEP caregivers with asthmatic children. Results of the  
study confirmed that these caregivers were more inclined to engage in ineffective 
communication with their healthcare providers and endured considerable burdens related to the 
long-term asthma management of their children. The study findings revealed a significant 
relationship between the levels of English proficiency and the functional health literacy of the 
participants. Previous research has linked both reduced health literacy levels and LEP in 
Hispanics to suboptimal medication adherence behaviors and inability to adequately self-manage 
asthma (McQuaid, 2018; White, 2015). Based on previous literature, it might be presumed that 
the results of this study would demonstrate a direct correlation between medication adherence 
behaviors and the level of English proficiency but no statistically significant difference was 
identified. For both the EP and LEP groups, essentially similar percentages of medication 
compliance were reported (p-value 1.0). Young et al. (2016) conducted a study to investigate the  
implications of the communication pathway that promoted improvement in patients’ use of 
asthma medication. The study findings confirmed that minority groups such as the Hispanics, 
who have lower levels of education, were more likely to experience discrepancies in asthma self-
management. Consequently, the influence of race/ethnicity and educational level on the self-
management of asthma were recognized as key factors leading to longstanding inconsistencies in 
asthma outcomes. Consistent with the findings of this study, a significant correlation between 
LEP and the level of education was observed among the Hispanic participants in our study as 
well, in conjunction with annual income, number of years with asthma, and the level of 
functional health literacy. The majority of the participants in the LEP group reported having an 
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educational level of a high school degree or less while 60% of the EP group reported having 
either a high school degree (or equivalent) or some college education without a degree.  
Furthermore, a significant relationship was identified between the difference in the number of 
years with asthma and the asthma quality of life. Most of the participants (~46%) in the study 
reported having asthma for more than 11 years. A majority of these participants felt that asthma 
caused a mild impairment to their overall quality of life. Out of the 54% of the participants who 
reported having asthma for less than 10 years (0-5 years and 6-10 years), 60% felt that their 
asthma severely impaired their quality of life. When compared with the level of English 
proficiency, most of the EP participants (52%) reported having asthma for more than 11 years 
while most of the LEP participants reported having asthma for less than 5 years. Based on these 
findings, it can be inferred that a majority of the EP participants felt their asthma had a mild 
impairment on their overall quality of life while the LEP patients reported asthma to impair their 
lives more severely. Furthermore, as the majority of the LEP patients from our findings reported 
being clinically diagnosed with asthma fairly recently, some underlying presumptions that could 
be deduced to corroborate this phenomena were that perhaps these patients: (a) lacked regular 
access to a primary care provider or clinic where they could receive asthma care; (b) did not have 
healthcare insurance; (c) were using alternative or traditional methods of asthma treatment; and 
(d) lacked trust in the healthcare system based on their sociocultural barriers. 
Association of LEP with health literacy 
 Previous research concludes that Hispanics, in general, have lower levels of health 
literacy compared to any other ethnic minority group (Sarkar et al., 2013). In their study, 
Wisnivesky et al. (2012) observed that elderly patients and ethnic minorities had higher rates of 
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low health literacy. Based on their findings, it was concluded that an association between LEP, 
low health literacy, and asthma outcome could be assumed. The level of functional health 
literacy was one of the major covariates observed in our study. While  
92% of the EP participants were found to have adequate health literacy, half of the LEP 
participants had inadequate health literacy. Consistent with previous literature, our research 
findings concluded the existence of a significant difference between the levels of functional 
health literacy and English proficiency. Similarly, Sarkar et al. (2016) found out that elevated 
levels of inadequate health literacy existed within all Hispanic subgroups. The relationship 
between health literacy and health outcomes was not confined to LEP but affected Hispanics 
with differing levels of English proficiency, even those who reported being bilingual. On the 
contrary, no statistically significant difference was evident in comparisons between health 
literacy, asthma outcomes, and medication adherence in our study. From their findings, Apter et 
al. (2013) confirmed that health literacy was directly associated with asthma outcomes and 
through interventions aimed at improving the health literacy needs of LEP patients, healthcare 
providers can promote better asthma outcomes.  
Limitations 
 Our study had some key limitations which may have influenced the final results. The 
small size of the representative sample (n = 37) and the LEP group (n = 12) may have reduced 
the strength to detect a statistically significant difference in the overall data. Due to unanticipated 
time constraints and other contingencies, a second set of data could not be collected by the 
researcher as initially planned. The results of the study, therefore, were analyzed based on the 
preliminary data. A convenience sampling method was utilized to recruit the participants from 
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the two clinics in the Kings and Tulare counties. Thus, our sample population mainly included 
Hispanics of Mexican descent while excluding a majority of the other Hispanic subgroups 
residing in other geographical locations. The participants in our study were all established 
patients under the care of asthma specialists during the study. Therefore, the findings 
of this study may not represent Hispanic patients with asthma in alternate healthcare settings that 
do not specialize in asthma management or patients who do not have regular access to asthma 
care. In addition, the healthcare providers in the clinics were not screened for their level of 
cultural competency and no observations were made regarding the effectiveness of the patient-
provider communication during the office visits.  
Conclusion 
 The adult Hispanic population in the US is extensively affected by the presence of LEP. 
The literature has linked LEP in this population with reduced access to healthcare services, 
misunderstanding of health and self-management information, decreased treatment adherence, 
ineffective communication with healthcare providers, lower health outcomes, and decline in the 
overall quality of care. While abundant research and treatment guideline information is available 
for children with asthma, there are indisputable gaps existing in the literature regarding Hispanic 
adults with moderate to severe persistent asthma. The purpose of this study was to determine if 
the presence of LEP is associated with adverse asthma outcomes and medication adherence 
behaviors in Hispanic adults aged 18 to 65 years old with moderate to severe persistent asthma, 
residing in the Kings and Tulare counties of California.  
 Thirty-seven participants were included in the study. Twenty-five of these participants 
were EP while the remaining 12 had LEP. Data was collected for asthma control, asthma quality 
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of life, medication adherence, health literacy, sociodemographic characteristics, comorbidities 
and asthma history. Three key findings were observed in our study: 1) we concluded that 
contrary to previous literature, there was no statistically significant difference identified between 
the level of English proficiency, asthma outcomes (asthma control and asthma quality of life) and  
medication adherence behaviors in our population; 2) consistent with previous literature, a 
statistically significant correlation was present between the level of English proficiency and the 
covariate variables: annual income, level of education, number of years with asthma, and the 
level of functional health literacy; and 3) a statistically significant difference was observed 
between the number of years with asthma and the asthma quality of life. Participants in the EP 
group who were diagnosed more than 11 years ago, reported that asthma had a mild impairment 
on their quality of life. Meanwhile, the LEP participants who had asthma for less than five years, 
reported that their asthma caused a severe impairment on their quality of life. 
Future research 
 Despite the limitations, the results from this study can be recognized as a fundamental 
step towards alleviating the gaps that currently exist in the literature regarding the long-term 
asthma outcomes and the medication adherence behaviors of the Hispanic adults who struggle 
with LEP. Future research should endeavor to conduct a longitudinal study consisting of a larger 
representative sample recruited via a probability sampling method to ensure valid and reliable 
conclusions, and to reduce the possibility of bias. The representative sample should also 
incorporate various Hispanic subgroups so that the findings from the study can be generalized to 
a larger population of adult Hispanics with moderate to severe persistent asthma who have LEP. 
Finally, since cultural beliefs play a crucial role in the self-management of asthma and other 
!40
chronic diseases, and the effectiveness of patient-provider communication has shown to improve 
long-term asthma outcomes, the inclusion of these variables in future research studies needs to 
be considered by researchers. 
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 APPENDICES 
 Appendix A: Consent Form 
CALIFORNIA STATE UNIVERSITY, NORTHERN CALIFORNIA CONSORTIUM 
DOCTOR OF NURSING PRACTICE 
CONSENT FORM FOR RESEARCH PARTICIPATION 
Study Title: Is there a relationship between limited English proficiency (LEP), medication 
adherence behaviors, and adverse asthma outcomes in Hispanic adults with moderate or severe 
persistent asthma? 
Principal Investigator: Archana Chandra, Nurse Practitioner 
Why are you doing this study? 
You are being asked to participate in a research study about Hispanic adults with moderate or 
severe persistent asthma. The aim of this study is to find out if Hispanic patients who speak 
English well have better controlled asthma than Hispanic patients who have difficulty speaking 
English.  
What will I do if I choose to be in this study? 
1. You will be asked to fill out questionnaires about: 
• English proficiency- will inform the researcher of how well you Speak English. 
• Medication Adherence- will inform the researcher of how often you use your controller 
medications for asthma. 
• Asthma control- will inform the researcher of how well your asthma is controlled by taking 
your current medications. 
• Quality of life- will inform the researcher of how satisfied you are with how well your asthma 
is controlled and the medications you are taking. 
• Health Literacy- will inform the researcher how well you understand health information. 
2. You will be asked to do a spirometry function test. This is the same test that you do at every 
follow up visit to find out what your lung function is. 
3. You will be asked to provider personal information such as age, gender, sex, average income 
earned in a year, and level of education. 
4. You will be asked to provide information regarding your asthma history such as the number of 
years you have had asthma, how often you have asthma flares, how often you have to go the 
emergency department, and if you have ever been intubated for a severe asthma flare. 
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Study time:  Study participation will take approximately 30 to 45 minutes per visit. After the 
initial visit, each participant will be asked to follow up at their assigned clinic (Visalia or 
Hanford) every 3 months for 6 months. This does not include any sick visits the participant has 
to schedule in between the required 3-month visits. 
Study location: All study procedures will take place at the Baz Allergy clinics in Visalia and 
Hanford. If you are a patient at the Visalia office, you will continue to schedule your visits at the 
Visalia office and vice versa. You will not be asked to travel to a different location at any time 
during the study. 
What are the possible risks or discomforts? 
To the best of my knowledge, your participation in this study will not involve any physical or 
emotional risk to you beyond that of everyday life. If you feel any emotional or psychological 
discomfort at any time during the interview, you may take a break or ask to stop the interview. If 
you feel uncomfortable with any of the questions, you may also choose to not answer the 
question or skip to the next question.  
What are the possible benefits for me or others? 
Taking part in this research study may not benefit you personally. This study is designed to learn 
more about Hispanic adults with asthma who have difficulty speaking English. The results from 
this study will be used to help patients in similar situations to improve the quality of their asthma 
care in the future. 
As with all research, there is a chance that confidentiality of the information we collect from you 
could be breached – we will take steps to minimize this risk. This is discussed in more detail 
below in this form. 
How will you protect the information you collect about me, and how will that information 
be shared? 
Results of this study may be used in presentations or publications in the future. Any information 
collected from you will be handled with utmost confidentiality. If the results of this study are 
presented or published, individual names, contact information, and any other information that 
could be used to identify you personally will never be used.  
To minimize the risks to confidentiality, each participant will be assigned a number and this 
number will linked to their information. Actual names of participants or other personal 
information will not be used to represent individual participants. All information will be stored in 
a locked cabinet at the researcher’s residence. After the completion of the research study all the 
data collected will be shredded and disposed of with utmost care. 
We may share the data we collect from you for use in future research studies or with other 
researchers – if we share the data that we collect about you, we will remove any information that 
could identify you before we share it. 
!48
If we think that you intend to harm yourself or others, we will notify the appropriate people with 
this information. 
Financial Information 
Participation in this study will involve no additional cost to you. Participating in this study is 
completely voluntary. You will not be paid for taking part in this study. 
What are my rights as a research participant? 
Participation in this study is completely voluntary. You do not have to answer any question you 
do not want to or feel uncomfortable answering. If at any time and for any reason, if you no 
longer prefer to participate in this study, please do not hesitate to inform the researcher. You can 
always ask to take a short break during your interview session, stop and continue at a later date, 
or withdraw from the study completely.  
Withdrawal from this study at any time or for any reason will not need an explanation and you 
will not be penalized in any way for your decision. If you decide to withdraw from this study 
before it is completed, any information collected from you will be disposed of with the utmost 
care and will not be used to determine the results of the study at its completion. 
Who can I contact if I have questions or concerns about this research study? 
If you have questions, you may contact the researcher at: 
(a) Baz Allergy, Asthma & Sinus Center (Visalia) 
Phone: (559) 713-1600 
Hours: 9am-6pm (Monday-Friday) 
Closed between the hours of 1-2pm (Monday-Friday) 
(b) Baz Allergy, Asthma & Sinus Center (Hanford) 
Phone: (559) 582-8500 
Hours: 9am-6pm (Monday-Friday) 
Closed between the hours of 1-2pm (Monday-Friday) 
Consent  
I have read the contents of this consent form and the research study has been explained to me. I 
have been given the opportunity to ask questions and all my questions have been answered to my 
satisfaction. If I have any additional questions, I have been told whom to contact. I agree to 
participate in the research study described above and will receive a copy of this consent form. 
______________________________________________________   
Participant’s Name (printed)           
______________________________________________________ ________________  
Participant’s Signature        Date 
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 Appendix B: Consent Form (Spanish) 
CALIFORNIA STATE UNIVERSITY, NORTHERN CALIFORNIA CONSORTIUM 
DOCTOR OF NURSING PRACTICE 
FORMULARIO DE CONSENTIMIENTO DE PARTICIPACIÓN EN INVESTIGACIÓN 
Título de Estudio: ¿Existe una relación entre el comportamiento de adherencia a medicamentos 
entre personas con dominio limitado del inglés (LEP, sus siglas en inglés), y los resultados 
adversos del asma en adultos Hispanos con asma persistente moderada o severa? 
Estudiante Realizando la Investigación: Archana Chandra, Enfermera Practicante Médica  
¿Por qué está realizando este estudio? 
Se le está pidiendo participar en este trabajo de investigación sobre adultos Hispanos asma 
persistente moderada o severa.  La meta de este estudio es descubrir si los pacientes Hispanos 
quienes hablan bien el inglés tienen mejor control de su asma que aquellos pacientes Hispanos 
quienes tienen dificultades para hablar inglés.     
¿Qué haré yo si decido participar en este estudio?  
1. Se le pedirá llenar un cuestionario sobre: 
• Dominio de Inglés- le informará al investigador qué tan bien habla usted inglés.    
• Adherencia a Medicamentos - le informará al investigador de la frecuencia con que usted usa 
sus medicamentos controladores de asma. 
• Control de Asma - le informará al investigador qué tan controlada esta su asma tomando los 
medicamentos actuales.  
• Calidad de vida- le informará al investigador qué tan satisfecho esta usted con lo bien que está 
controlada su asma y con los medicamentos que está tomando.    
• Educación de Salud- le informará al investigador qué tan bien entiende usted la información 
médica.    
2. Se le pedirá realizar una prueba funcional de espirometría. Esta es la misma prueba que usted 
hace en cada cita de seguimiento para descubrir su capacidad de funcionamiento pulmonar.                                      
3. Se le pedirá que proporcione su información personal tal como edad, género, sexo, promedio 
de ingreso anual y nivel de preparación escolar. 
4. Se le pedirá proporcionar información sobre su historial del asma tal como cuántos años ha 
sufrido de asma, qué tan seguido tiene usted crisis de asma, qué tan seguido ha ido a la 
emergencia, y si lo han entubado por una crisis grave de asma.   
Tiempo del Estudio:  La participación en el estudio tomará aproximadamente 30 a 45 minutos 
por visita. Después de la visita inicial, a cada participante se le pedirá que dé seguimiento con su 
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clínica asignada (Visalia o Hanford) en 3 meses. Esto no incluye visitas por enfermedades que el 
participante tenga que programar entre la visita de 3 meses requerida.   
Localidad del Estudio: Todo trámite de estudio se llevará acabo en las clínicas Baz Allergy en 
Visalia y Hanford. Si usted es paciente en el consultorio de Visalia, usted seguirá acudiendo a 
citas en Visalia y vice versa. No se le pedirá que viaje a otra localidad en ningún momento 
durante el estudio.    
¿Cuáles son los posibles riesgos o molestias? 
Según lo mejor de mi conocimiento su participación en este estudio no le ocasionará ningún 
riesgo físico o emocional a usted mayor a lo que le cause su vida cotidiana.  Si usted siente 
cualquier molestia emocional o psicológica en cualquier momento durante la entrevista, usted se 
puede tomar un descanso o pedir que se pare la entrevista.  Si se siente incómodo con alguna 
pregusta, también puede optar por no contestarla o pasar a la siguiente pregunta.  
¿Cuáles son los posibles beneficios para mi y los demás?  
El participar en esta investigación quizá no le beneficie a usted en lo personal.  Este estudio está 
diseñado para aprender más a cerca de los adultos Hispanos con asma que tienen dificultad para 
hablar el inglés.  Los resultados de este estudio se usarán para ayudar a pacientes en situaciones 
similares a mejorar la calidad de su cuidado del asma en el futuro.    
Como con toda investigación, existe la posibilidad de que pueda ocurrir una transgresión a la 
confidencialidad de la información que obtengamos de usted– tomaremos todas las medidas para 
minimizar este riesgo.  Esto se aborda en más detalle en la parte inferior de este formulario.  
   
¿Cómo se protegerá la información que obtenga de mi, y cómo se compartirá esta 
información? 
Los resultados de este estudio se pueden usar en presentaciones o publicaciones en el futuro. 
Toda información obtenida de usted se manejará con la más estricta confidencialidad.  Si los 
resultados de este estudio son presentados o publicados, los nombres individuales, información 
de contacto y cualquier otra información que se pudiera usar para identificarlo a usted 
personalmente nunca se utilizará.    
Para amenorar riesgos a la confidencialidad, a cada participante se le asignará un número y este 
número estará enlazado a su información. Los nombres de los participantes u otra información 
personal no se usarán para representar a los participantes individuales.  Toda la información se 
almacenará en un gabinete bajo candado en la residencia del investigador.  Una vez que concluya 
la investigación todos los datos colectados serán destruidos y deshechos con el mayor de los 
cuidados.      
Puede que compartamos datos que obtuvimos de usted para uso en estudios de investigación en 
el futuro o con otros investigadores – si llegáramos a compartir datos sobre usted, removeremos 
cualquier información que lo identifique antes de compartirlo.     
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Si creemos que usted tiene intención de lastimares a si mismo o a otros, notificaremos a las 
personas adecuadas con esta información. 
Información Financiera  
La participación en este estudio no significará ningún costo adicional para usted. Participar en 
este estudio es completamente voluntario.  No se le pagará por participar en el estudio.    
¿Cuáles son mis derechos como participante del estudio?  
Participar en este estudio es completamente voluntario. Usted no tiene obligación de contestar 
cualquier pregunta que no quiera o que se sienta incomodo contestando.  Si en cualquier 
momento y por cualquier motivo, prefiere ya no seguir participando en el estudio, por favor no 
vacile en informárselo al investigador.  Siempre podrá tomarse un pequeño descanso durante la 
entrevista, parar la sesión para seguir en otra fecha o darse de baja completamente del estudio. 
Si se da de baja del estudio en cualquier momento, por cualquier motivo no es necesario que dé 
una explicación y no será penalizado de ninguna forma por su decisión.   Si usted decide retirase 
del estudio antes de que se complete, todos los datos colectados serán deshechos con el mayor 
cuidado y no se usarán para determinar los resultados del estudio cuando este concluya.      
¿Con quién me comunico si tengo preguntas o inquietudes sobre este estudio? 
Si tiene preguntas, puede contactarse con el investigador en:   
(a) Baz Allergy, Asthma & Sinus Center (Visalia) 
Tel: (559) 713-1600 
Horario: 9am-6pm (Lunes-Viernes) 
Cierran entre 1-2pm (Lunes-Viernes) 
(b) Baz Allergy, Asthma & Sinus Center (Hanford) 
Tel: (559) 582-8500 
Horario: 9am-6pm (Lunes-Viernes) 
Cierran entre 1-2pm (Lunes-Viernes) 
Consentimiento  
He leído el contenido de este formulario de consentimiento y se me ha explicado el estudio.  Se 
me ha dado la oportunidad de hacer preguntas y todas se han contestado a mi satisfacción.  Si 
tengo más preguntas, me han dicho con quien contactarme.  Estoy de acuerdo en participar en 
este estudio de investigación como se describe anteriormente y se me entregará una copia de este 
consentimiento.    
______________________________________________________   
Nombre del Participante (en letra de molde)       
    
______________________________________________________ ________________  
Firma del Participante        Fecha 
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 Appendix C: Short Test of Functional Health Literacy (S-TOFHLA) 
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Appendix D: Short Test of Functional Health Literacy (S-TOFHLA) (Spanish)
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Appendix E: Asthma Control Questionnaire (ACQ)
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Appendix F: Asthma Control Questionnaire (ACQ) (Spanish)
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Appendix G: Asthma Quality of Life Questionnaire
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Appendix H: Asthma Quality of Life Questionnaire (Spanish)
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Appendix I: Medication Adherence Rating Scale (MARS)
Medication Adherence Rating Scale (MARS) 
This scale is based on two already existing self-report measures of compliance.  The 
first is the Drug Attitude Inventory (DAI) (Hogan, Awad and Eastwood, 1983), and the 
second is the Medication Adherence Questionnaire (MAQ) (Morisky, Green and Levine, 
1986).  These compliance measures have been combined to produce a compliance 
scale. 
The MARS consists of 10 items that require yes/no responses.  The first 4 items are 
based on the MAQ, and are scored, no = 1 and yes = 0.  The remaining items are from 
the DAI and are coded as follows: Q5, Q6, Q9, Q10, no = 1 and yes = 0; Q7, Q8, no = 0 
and yes = 1.  A total score will then reflect a greater degree of compliance if it is high, 
and non-compliance if it is low.  However one must always keep in mind that any 
measure of self-reported compliance will overestimate compliance by approximately 
30%. 
Hogan, T P, Awad, A G, and Eastwood, R (1983) A self-report scale predictive of drug 
compliance in schizophrenics: reliability and discriminative validity, Psychological 
Medicine, 13, 177-183. 
Morisky, D E, Green, L W, and Levine, D M (1986) Concurrent and predictive validity of 
a self-reported measure of medication adherence.  Medical Care, 24(1), 67-74. 
____________________________________________________________ 
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Dr Katherine Thompson 
Senior Research Fellow, 
HYPE Clinic  
35 Poplar Road Parkville VIC 3052 
Australia  
katherine.thompson@unimelb.edu.au 
orygen.org.au 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Medication Adherence Rating Scale 
Please respond to the following statements by circling the response which best 
describes your behaviour or the attitude you have held toward your medication in the 
past week. 
1. Do you ever forget to take your medication?    Yes / No 
2. Are you careless at times about taking your medicine?  Yes / No 
3. When you feel better, 
 do you sometimes stop taking your medicine?   Yes / No 
4. Sometimes if you feel worse when you take the medicine, 
 do you stop taking it?       Yes / No 
5. I take my medication only when I am sick    Yes / No 
6. It is unnatural for my mind and body 
 to be controlled by medication      Yes / No 
7. My thoughts are clearer on medication    Yes / No 
8. By staying on medication I can prevent getting sick   Yes / No 
9. I feel weird, like a “zombie”, on medication    Yes / No 
10. Medication makes me feel tired and sluggish   Yes / No 
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 Appendix J: Medication Adherence Rating Scale (MARS) (Spanish) 
Escala de Evaluación de Adherencia a Medicamentos (MARS) 
Esta escala se basa en dos medidas del cumplimento de autoinforme ya existentes.  La 
primera es el Inventario de Actitud a Medicamentos (DAI) (Hogan, Awad y Eastwood, 
1983), y la segunda es el Cuestionario de Adherencia a Medicamentos (MAQ) (Morisky, 
Green y Levine, 1986). Estas medidas del cumplimiento se han combinado para 
producir la escala de cumplimiento. 
El MARS consiste de 10 preguntas/declaraciones que requieren respuestas de sí/no. 
Las primeras 4 se basan en el MAQ, y se califican así: no = 1 y sí = 0.  Las restantes 
son del DAI y se codifican de la siguiente forma: Q5, Q6, Q9, Q10, no = 1 y sí = 0; Q7, 
Q8, no = 0 y sí = 1.  La suma total entonces reflejará un mayor grado de cumplimiento 
si el resultado es alto y de no cumplimiento si es bajo.  Sin embargo, uno debe 
considerar que cualquier medida del cumplimiento auto informado sobreestimará el 
cumplimiento por aproximadamente 30%. 
Hogan, T P, Awad, A G, y Eastwood, R (1983) Escala de autoinforme predecible de 
cumplimiento de medicamentos en esquizofrenia: fiabilidad y validez discriminatoria, 
Medicina Psicológica, 13, 177-183. 
Morisky, D E, Green, L W, y Levine, D M (1986) Validez concurrente y predecible de 
medidas de autoinforme de adherencia a medicamento.  Cuidado Médico, 24(1), 67-74. 
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Escala de Evaluación de Adherencia a Medicamentos 
Por favor conteste a las siguientes declaraciones haciendo un círculo alrededor de la 
respuesta que mejor describa su comportamiento o actitud hacia su medicamento en la 
semana pasada.  
1. ¿Se le ha olvidado a veces tomar su medicamento?  Sí / No 
2. ¿Es a veces descuidado(a) para tomar su medicina?  Sí / No 
3. ¿Cuando se siente mejor, a veces deja de tomar su 
medicina?         Sí / No 
4. ¿A veces, si se siente peor cuando se toma la medicina,  
deja de tomarla?         Sí / No  
      
5. Yo me tomo el medicamento sólo cuando estoy enfermo(a). Sí / No 
6. Es antinatural para mi mente y mi cuerpo estar controlado  
por medicamento.       Sí / No 
7. Mis pensamientos están más claros cuando tomo la medicina. Sí / No 
8. Al seguir tomando los medicamentos puedo prevenir  
enfermarme.        Sí / No 
9. Me siento raro(a), como “zombi”, tomando la medicina.  Sí / No 
  
10. El medicamento me hace sentir cansado(a) y  
           perezoso(a)        Sí / No
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